Outcomes of pregnancy in women with autoimmune hepatitis

Journal of Autoimmunity

Volumn 38, Issue 2-3, 2012, Pages

  Westbrook, Rachel H ^a   Yeoman, Andrew D ^a   Kriese, Stephen ^a   Heneghan, Michael A ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Autoimmune hepatitism; Live birth rate; Outcomes; Pregnancy

Indexed keywords

AZATHIOPRINE; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; AUTOIMMUNE HEPATITIS; BIRTH RATE; CEREBRAL PALSY; CONCEPTION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE DURATION; END STAGE LIVER DISEASE; FEMALE; FERTILIZATION IN VITRO; FETUS OUTCOME; GESTATION PERIOD; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVE BIRTH; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MONOTHERAPY; NEWBORN; NEWBORN INTENSIVE CARE; PATIENT COUNSELING; PERTHES DISEASE; PREDICTIVE VALUE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELECTIVE ABORTION; SPONTANEOUS ABORTION;

ADOLESCENT; ADULT; FEMALE; FERTILIZATION; FIBROSIS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROGNOSIS; REPRODUCTIVE TECHNIQUES, ASSISTED; YOUNG ADULT;

EID: 84858747785     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.12.002     Document Type: Article

References (25)

1. Leber Waldenström J. Blutproteine und Nahrungseiweib. Dtsch Z Verdau Stoffwechselkr 1950, 15:113-119.
2. Steven M.M., Buckley J.D., Mackay I.R. Pregnancy in chronic active hepatitis. Q J Med 1979, 48:519-531.
3. Whelton M.J., Sherlock S. Pregnancy in patients with hepatic cirrhosis. management and outcome. Lancet 1968, 2:995-999.
4. Heneghan M.A., Norris S.M., O'Grady J.G., Harrison P.M., McFarlane I.G. Management and outcome of pregnancy in autoimmune hepatitis. Gut 2001, 48:97-102.
5. Terrabuio D.R., Abrantes-Lemos C.P., Carrilho F.J., Cancado E.L. Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes. J Clin Gastroenterol 2009, 43:350-356.
6. Schramm C., Herkel J., Beuers U., Kanzler S., Galle P.R., Lohse A.W. Pregnancy in autoimmune hepatitis: outcome and risk factors. Am J Gastroenterol 2006, 101:556-560.
7. Buchel E., Van Steenbergen W., Nevens F., Fevery J. Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery. Am J Gastroenterol 2002, 97:3160-3165.
8. Penney G.C., Mair G., Pearson D.W. Outcomes of pregnancies in women with type 1 diabetes in Scotland: a national population-based study. BJOG 2003, 110:315-318.
9. Hay J.E. Liver disease in pregnancy. Hepatology 2008, 47:1067-1076.
10. Joshi D., James A., Quaglia A., Westbrook R.H., Heneghan M.A. Liver disease in pregnancy. Lancet 2010, 375:594-605.
11. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999, 31:929-938.
12. Czaja A.J., Menon K.V., Carpenter H.A. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis. Hepatology 2002, 35:890-897.
13. Longhi M.S., Ma Y., Mitry R.R., Bogdanos D.P., Heneghan M., Cheeseman P., et al. Effect of CD4 + CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 2005, 25:63-71.
14. Longhi M.S., Hussain M.J., Mitry R.R., Arora S.K., Mieli-Vergani G., Vergani D., et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006, 176:4484-4491.
15. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004, 5:266-271.
16. Aluvihare V.R., Kallikourdis M., Betz A.G. Tolerance, suppression and the fetal allograft. J Mol Med 2005, 83:88-96.
17. Tuchmann-Duplessis H., Mercier-Parot L. [Production in rabbits of malformations of the extremities by administration of azathioprine and 6-mercaptopurine]. C R Seances Soc Biol Fil 1966, 160:501-506.
18. Rosenkrantz J.G., Githens J.H., Cox S.M., Kellum D.L. Azathioprine (Imuran) and pregnancy. Am J Obstet Gynecol 1967, 97:387-394.
19. DeWitte D.B., Buick M.K., Cyran S.E., Maisels M.J. Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone. J Pediatr 1984, 105:625-628.
20. Danesi R., Del Tacca M. Teratogenesis and immunosuppressive treatment. Transplant Proc 2004, 36:705-707.
21. Christopher V., Al-Chalabi T., Richardson P.D., Muiesan P., Rela M., Heaton N.D., et al. Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl 2006, 12:1138-1143.
22. Angelberger S., Reinisch W., Messerschmidt A., Miehsler W., Novacek G., Vogelsang H., et al. Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis 2011, 5:95-100.
23. Peyrin-Biroulet L., Oussalah A., Roblin X., Sparrow M.P. The use of azathioprine in Crohn's disease during pregnancy and in the post-operative setting: a worldwide survey of experts. Aliment Pharmacol Ther 2011, 33:707-713.
24. Hogan M.C., Foreman K.J., Naghavi M., Ahn S.Y., Wang M., Makela S.M., et al. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010, 375:1609-1623.
25. Westbrook R.H., Yeoman A.D., O'Grady J.G., Harrison P.M., Devlin J., Heneghan M.A. Model for end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy. Clin Gastroenterol Hepatol 2011, 9:694-699.